Glutamate receptor antagonists: fused cycloalkylouinoxalinedione

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544344, 562433, 562434, 552 8, 564218, 560 20, 560 21, C07D24138, C07D40112, C07D40512, A61K 31495

Patent

active

057212341

ABSTRACT:
Novel glutamate receptor antagonists represented by the formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein

REFERENCES:
patent: 4889855 (1989-12-01), Jacobsen et al.
patent: 5081123 (1992-01-01), Honore et al.
patent: 5308845 (1994-05-01), Honore et al.
patent: 5389687 (1995-02-01), Schaus et al.
K. Lippert et al., Eur. J. Pharmacol. 253 (3), 207-13 (1994).
W. Loescher et al., Eur. J. Neurosci. 5(11), 1545-50 (1993).
J. Mosinger et al., Exp. Neurol. 113, 10-17 (1991).
C.F. Bigge and T.C. Malone, Curr. Opin. Ther. Pat., 951 (1993).
M. A. Rogawski, TiPS 14, 325 (1993).
H. Li and A.M. Buchan, J. Cerebr. Blood Flow Metab. 13, 933 (1993).
B. Nellgard and T. Wieloch, J. Cerebr. Blood Flow Metab. 12, 2 (1992).
R. Bullock et al., J. Cerebr. Blood Flow Metab. 14, 466 (1994).
D. Xue et al., J. Cerebr. Blood Flow Metab. 14, 251 (1994).
X.-J. Xu et al., J. Pharmacol. Exp. Ther. 267, 140 (1993).
T. Namba et al., Brain Res. 638, 36 (1994).
S. E. Browne and J. McCulloch, Brain Res. 641, 10 (1994).
S.I. Yamaguchi et al., Epilepsy Res. 15, 179 (1993).
S.E. Smith et al., Eur. J. Pharmacol. 201, 179 (1991).
T. Klockgether et al., Ann Neurol. 34 (4), 585-593 (1993).
P.T. Francis et al., J. Neurochem. 60 (5), 1589-1604 (1993).
S. Lipton, TINS 16 (12), 527-532 (1993).
S. Lipton et al., New Eng. J. Med. 330 (9), 613-622 (1994).
C.F. Bigge, Biochem Pharmacol. 45, 1547-1561 (1993).
A.M. Buchan et al., Neurosci. Lett (Ireland) 132 (2), 255-8 (1991).
L. Dalgaard et al., Drug Metabolism and Disposition 22 (2), 289-93 (1994).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Glutamate receptor antagonists: fused cycloalkylouinoxalinedione does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glutamate receptor antagonists: fused cycloalkylouinoxalinedione, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glutamate receptor antagonists: fused cycloalkylouinoxalinedione will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1875336

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.